KeifeRx, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease (NCT05143528) | KeifeRx, LLC | 2022-02-01 |
Track KeifeRx, LLC automatically
Every clearance here is in the API, with alerts when new ones post.